Key messages
• The infection prevention and control (IPC) measures for Ebola disease described in this document are aimed at preventing the transmission of ebolaviruses in the EU/EEA from the time of symptom onset through hospitalisation, with the understanding that ebolavirus transmission requires direct contact with infected individuals or their body fluids.
° Ebola disease IPC measures start with the assessment of whether a symptomatic person meets clinical and epidemiological criteria outlined in the definition of a ‘person under investigation’ (PUI) for Ebola disease.
° Such assessment should be conducted as soon as possible, even prior to physical contact with symptomatic individuals and prior to arrival at a hospital.
• Ebola disease is a high-consequence infectious disease (HCID) with high case fatality and limited effective medical countermeasures.
° Its transmission begins at symptom onset.
• Strict multi-level IPC measures are warranted for Ebola disease, including the use of high-level isolation units if possible/where available.
• IPC measures to prevent the transmission of Ebola disease are well established, with successful implementation during prior outbreaks.
ECDC rapid scientific advice disclosure statement:
ECDC issues rapid scientific advice to meet an emergent or urgent public health need or to quickly reply to external requests.
To accommodate the accelerated timeline, the process and methods used for the development of rapid scientific advice may be modified from those of standard assessments and recommendations.
Potential limitations are described.
(...)
Source:
____
No comments:
Post a Comment